nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—Doxylamine—Tamoxifen—pancreatic cancer	0.104	0.188	CrCrCtD
Brompheniramine—Tripelennamine—Tamoxifen—pancreatic cancer	0.0937	0.17	CrCrCtD
Brompheniramine—Bromodiphenhydramine—Tamoxifen—pancreatic cancer	0.0876	0.159	CrCrCtD
Brompheniramine—Clofedanol—Tamoxifen—pancreatic cancer	0.0711	0.129	CrCrCtD
Brompheniramine—Orphenadrine—Tamoxifen—pancreatic cancer	0.0688	0.125	CrCrCtD
Brompheniramine—Promazine—Tamoxifen—pancreatic cancer	0.0657	0.119	CrCrCtD
Brompheniramine—Diphenhydramine—Tamoxifen—pancreatic cancer	0.0611	0.111	CrCrCtD
Brompheniramine—CYP2E1—Dacarbazine—pancreatic cancer	0.0436	0.111	CbGbCtD
Brompheniramine—KCNH2—Sunitinib—pancreatic cancer	0.0393	0.0999	CbGbCtD
Brompheniramine—CYP2E1—Tamoxifen—pancreatic cancer	0.0347	0.0881	CbGbCtD
Brompheniramine—CYP2B6—Tamoxifen—pancreatic cancer	0.0342	0.0869	CbGbCtD
Brompheniramine—CYP2B6—Irinotecan—pancreatic cancer	0.0262	0.0667	CbGbCtD
Brompheniramine—CYP2C8—Tamoxifen—pancreatic cancer	0.0259	0.0658	CbGbCtD
Brompheniramine—CYP2C8—Erlotinib—pancreatic cancer	0.022	0.0559	CbGbCtD
Brompheniramine—CYP2C19—Tamoxifen—pancreatic cancer	0.0217	0.0552	CbGbCtD
Brompheniramine—CYP2C8—Fluorouracil—pancreatic cancer	0.0191	0.0485	CbGbCtD
Brompheniramine—CYP2C9—Tamoxifen—pancreatic cancer	0.0181	0.0459	CbGbCtD
Brompheniramine—CYP2D6—Tamoxifen—pancreatic cancer	0.0165	0.042	CbGbCtD
Brompheniramine—CYP2B6—Doxorubicin—pancreatic cancer	0.0143	0.0364	CbGbCtD
Brompheniramine—CYP2D6—Erlotinib—pancreatic cancer	0.014	0.0357	CbGbCtD
Brompheniramine—CYP2C9—Fluorouracil—pancreatic cancer	0.0133	0.0338	CbGbCtD
Brompheniramine—CYP3A4—Tamoxifen—pancreatic cancer	0.0105	0.0267	CbGbCtD
Brompheniramine—CYP3A4—Erlotinib—pancreatic cancer	0.00893	0.0227	CbGbCtD
Brompheniramine—CYP3A4—Irinotecan—pancreatic cancer	0.00806	0.0205	CbGbCtD
Brompheniramine—CYP2D6—Doxorubicin—pancreatic cancer	0.00693	0.0176	CbGbCtD
Brompheniramine—CYP3A4—Docetaxel—pancreatic cancer	0.00591	0.015	CbGbCtD
Brompheniramine—CYP3A4—Sunitinib—pancreatic cancer	0.00588	0.0149	CbGbCtD
Brompheniramine—CYP3A4—Doxorubicin—pancreatic cancer	0.0044	0.0112	CbGbCtD
Brompheniramine—CHRM4—Signaling by GPCR—HRAS—pancreatic cancer	6.34e-06	0.000116	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KDR—pancreatic cancer	6.33e-06	0.000116	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KDR—pancreatic cancer	6.26e-06	0.000114	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.18e-06	0.000113	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—TYMS—pancreatic cancer	6.17e-06	0.000113	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—AKT1—pancreatic cancer	6.17e-06	0.000113	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.14e-06	0.000112	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CD—pancreatic cancer	6.13e-06	0.000112	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL8—pancreatic cancer	6.11e-06	0.000112	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CASP3—pancreatic cancer	6.11e-06	0.000112	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—HRAS—pancreatic cancer	6.07e-06	0.000111	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	6.06e-06	0.000111	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	6.04e-06	0.00011	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	6.02e-06	0.00011	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	6e-06	0.00011	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	6e-06	0.00011	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	5.98e-06	0.000109	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	5.96e-06	0.000109	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	5.96e-06	0.000109	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CCND1—pancreatic cancer	5.95e-06	0.000109	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—AKT1—pancreatic cancer	5.91e-06	0.000108	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	5.9e-06	0.000108	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CTNNB1—pancreatic cancer	5.89e-06	0.000108	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	5.87e-06	0.000107	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	5.86e-06	0.000107	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	5.86e-06	0.000107	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CASP3—pancreatic cancer	5.85e-06	0.000107	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	5.85e-06	0.000107	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	5.85e-06	0.000107	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	5.83e-06	0.000106	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	5.83e-06	0.000106	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGF—pancreatic cancer	5.8e-06	0.000106	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PPARG—pancreatic cancer	5.79e-06	0.000106	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGF—pancreatic cancer	5.78e-06	0.000106	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP9—pancreatic cancer	5.77e-06	0.000106	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	5.77e-06	0.000105	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	5.77e-06	0.000105	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGF—pancreatic cancer	5.76e-06	0.000105	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PTEN—pancreatic cancer	5.74e-06	0.000105	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	5.7e-06	0.000104	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CCND1—pancreatic cancer	5.7e-06	0.000104	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.68e-06	0.000104	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PPARG—pancreatic cancer	5.67e-06	0.000104	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CTNNB1—pancreatic cancer	5.64e-06	0.000103	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—TYMS—pancreatic cancer	5.63e-06	0.000103	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—APOE—pancreatic cancer	5.62e-06	0.000103	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—AKT1—pancreatic cancer	5.6e-06	0.000102	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP9—pancreatic cancer	5.53e-06	0.000101	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PTEN—pancreatic cancer	5.5e-06	0.0001	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—AKT1—pancreatic cancer	5.36e-06	9.8e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	5.34e-06	9.76e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CB—pancreatic cancer	5.34e-06	9.76e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	5.33e-06	9.73e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.32e-06	9.73e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SRC—pancreatic cancer	5.32e-06	9.73e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	5.31e-06	9.7e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS2—pancreatic cancer	5.29e-06	9.67e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	5.27e-06	9.63e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	5.26e-06	9.61e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—VEGFA—pancreatic cancer	5.19e-06	9.48e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	5.16e-06	9.43e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	5.16e-06	9.42e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	5.14e-06	9.39e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—STAT3—pancreatic cancer	5.13e-06	9.38e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	5.12e-06	9.36e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NRAS—pancreatic cancer	5.12e-06	9.36e-05	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.11e-06	9.33e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SRC—pancreatic cancer	5.1e-06	9.32e-05	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.09e-06	9.3e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	5.08e-06	9.28e-05	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.07e-06	9.27e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	5.07e-06	9.27e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	5.05e-06	9.22e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	5.03e-06	9.19e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.02e-06	9.18e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—APOE—pancreatic cancer	5.02e-06	9.17e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	5.02e-06	9.17e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	4.97e-06	9.08e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—VEGFA—pancreatic cancer	4.97e-06	9.07e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT3—pancreatic cancer	4.92e-06	8.98e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NRAS—pancreatic cancer	4.9e-06	8.96e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PPARG—pancreatic cancer	4.9e-06	8.95e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CD44—pancreatic cancer	4.79e-06	8.75e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MYC—pancreatic cancer	4.77e-06	8.72e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—pancreatic cancer	4.76e-06	8.7e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.75e-06	8.68e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—EGFR—pancreatic cancer	4.67e-06	8.53e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.64e-06	8.47e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.62e-06	8.45e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APOE—pancreatic cancer	4.62e-06	8.44e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTEN—pancreatic cancer	4.61e-06	8.43e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	4.61e-06	8.42e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	4.59e-06	8.4e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GCG—pancreatic cancer	4.59e-06	8.39e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APOE—pancreatic cancer	4.58e-06	8.36e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MYC—pancreatic cancer	4.57e-06	8.35e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	4.56e-06	8.34e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—pancreatic cancer	4.56e-06	8.33e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—pancreatic cancer	4.55e-06	8.32e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	4.53e-06	8.28e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	4.5e-06	8.22e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	4.49e-06	8.21e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	4.48e-06	8.19e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—EGFR—pancreatic cancer	4.47e-06	8.17e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	4.47e-06	8.16e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	4.46e-06	8.15e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—pancreatic cancer	4.46e-06	8.15e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	4.42e-06	8.08e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—KRAS—pancreatic cancer	4.41e-06	8.06e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PPARG—pancreatic cancer	4.37e-06	7.99e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.33e-06	7.92e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	4.32e-06	7.89e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—STK11—pancreatic cancer	4.32e-06	7.89e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	4.3e-06	7.87e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	4.29e-06	7.84e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	4.29e-06	7.84e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	4.28e-06	7.82e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	4.26e-06	7.79e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	4.25e-06	7.77e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	4.22e-06	7.72e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—KRAS—pancreatic cancer	4.22e-06	7.71e-05	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	4.17e-06	7.62e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	4.17e-06	7.62e-05	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	4.16e-06	7.6e-05	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	4.15e-06	7.58e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	4.13e-06	7.55e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	4.13e-06	7.55e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	4.12e-06	7.53e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	4.11e-06	7.51e-05	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	4.1e-06	7.5e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	4.07e-06	7.43e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PIK3CA—pancreatic cancer	4.05e-06	7.4e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	4.02e-06	7.35e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARG—pancreatic cancer	4.02e-06	7.35e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	4.01e-06	7.33e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	4e-06	7.31e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.99e-06	7.29e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	3.98e-06	7.28e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.98e-06	7.28e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	3.97e-06	7.26e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTEN—pancreatic cancer	3.97e-06	7.25e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	3.96e-06	7.23e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	3.96e-06	7.23e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	3.92e-06	7.16e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—pancreatic cancer	3.92e-06	7.16e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	3.91e-06	7.14e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	3.89e-06	7.12e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	3.89e-06	7.11e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTEN—pancreatic cancer	3.89e-06	7.11e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	3.88e-06	7.1e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	3.88e-06	7.09e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	3.88e-06	7.09e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	3.87e-06	7.07e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	3.86e-06	7.05e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	3.85e-06	7.04e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	3.84e-06	7.02e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	3.82e-06	6.98e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	3.79e-06	6.92e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	3.78e-06	6.9e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	3.76e-06	6.88e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—pancreatic cancer	3.75e-06	6.86e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	3.75e-06	6.85e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	3.73e-06	6.81e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.71e-06	6.78e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.66e-06	6.69e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.63e-06	6.64e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SRC—pancreatic cancer	3.6e-06	6.58e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	3.59e-06	6.56e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	3.59e-06	6.56e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	3.58e-06	6.54e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	3.54e-06	6.48e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	3.51e-06	6.41e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	3.5e-06	6.39e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	3.49e-06	6.37e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	3.47e-06	6.35e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.47e-06	6.34e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	3.46e-06	6.33e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	3.46e-06	6.33e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	3.45e-06	6.31e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	3.45e-06	6.31e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	3.45e-06	6.31e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	3.44e-06	6.29e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.44e-06	6.29e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	3.42e-06	6.24e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	3.41e-06	6.23e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTEN—pancreatic cancer	3.36e-06	6.14e-05	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	3.31e-06	6.05e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	3.26e-06	5.95e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MYC—pancreatic cancer	3.23e-06	5.9e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	3.22e-06	5.88e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	3.22e-06	5.88e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	3.21e-06	5.86e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	3.21e-06	5.86e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	3.2e-06	5.85e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.19e-06	5.84e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	3.18e-06	5.8e-05	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	3.17e-06	5.79e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	3.17e-06	5.79e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.17e-06	5.78e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.16e-06	5.78e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	3.16e-06	5.77e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	3.15e-06	5.75e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.14e-06	5.73e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	3.14e-06	5.73e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	3.11e-06	5.68e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APOE—pancreatic cancer	3.02e-06	5.52e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTEN—pancreatic cancer	3e-06	5.48e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	2.98e-06	5.45e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	2.97e-06	5.43e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	2.96e-06	5.41e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	2.93e-06	5.36e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	2.8e-06	5.12e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.76e-06	5.04e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	2.74e-06	5.01e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	2.74e-06	5.01e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.74e-06	5e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.73e-06	4.99e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.72e-06	4.98e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.72e-06	4.97e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.7e-06	4.93e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AKT1—pancreatic cancer	2.66e-06	4.86e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—pancreatic cancer	2.65e-06	4.84e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	2.64e-06	4.83e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	2.63e-06	4.81e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.63e-06	4.81e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	2.61e-06	4.77e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	2.53e-06	4.63e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	2.53e-06	4.62e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	2.52e-06	4.6e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2.49e-06	4.56e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.4e-06	4.38e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	2.37e-06	4.33e-05	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AKT1—pancreatic cancer	2.29e-06	4.18e-05	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AKT1—pancreatic cancer	2.24e-06	4.09e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	2.24e-06	4.09e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	2.23e-06	4.08e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	2.22e-06	4.06e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	2.2e-06	4.02e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.12e-06	3.87e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.09e-06	3.81e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.07e-06	3.78e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.95e-06	3.56e-05	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.94e-06	3.54e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.93e-06	3.53e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.8e-06	3.3e-05	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.73e-06	3.16e-05	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.59e-06	2.91e-05	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.58e-06	2.88e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.27e-06	2.33e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.04e-06	1.9e-05	CbGpPWpGaD
